Project Scope

To develop a launch strategy for cystic fibrosis products through mapping KOLs and payers and conducting extensive primary research

Challenge

Our client has a focus on Cystic fibrosis research and treatment and wanted to put together a business case for senior leadership to pursue NPS or registration & reimbursement in Jordan, a new market

Solution

Mapping KOLs and payers, Extensive primary research

• Conducted a mapping exercise to recruit top KOLs and payers for the discussion
• Conducted discussions with relevant stakeholders to understand the criteria needed to establish a Named Patient Program, the approval process, funding and pricing of such medicines, the market authorization process and procurement channels including distribution and tender processes

Results

• Understood the market authorization and reimbursement pathways for orphan drugs, and if NPS is feasible
• Understood the drivers behind market access for orphan drugs and the procurement process, the wholesaler and distributor margins and tender processes